Germline Integration Assessment in Preclinical Gene Therapy Studies
Key Considerations for Nonclinical AAV Gene Therapy Development
Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Case Study—Nanosuspension Formulation to Maximize Potency for Preclinical Studies
BioPharma Dive: How Biotech Companies and CROs Can Better Align to Accelerate Development for the Most Promising Discoveries
Insights Success: Five Leading Companies Supporting the Future of Medicine
Internships at Altasciences: Q&A With Our Summer Interns
Internships at Altasciences are more than just a stepping stone—they’re a gateway to real-world-experience and professional growth, giving the next generation opportunities to help shape progress in the drug development industry. This summer’s interns brought dedication and fresh perspectives to our operations, and we asked a few of them to share what they’ve learned.
Read what they had to say in this Q&A:
How Improving Diversity Can Benefit Clinical Trials
In June 2024, the U.S. Food and Drug Administration (FDA) published a draft guidance to ensure greater diversity in clinical trials, which is expected to become a final guidance by June 2025.